Raleigh Capital Management’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
Other funds holding STAA
BC
AIM
PAI
GCM
EFM
Raleigh Capital Management's STAA Position: Q1 2023 in Review
Raleigh Capital Management sold out of STAAR Surgical (STAA) in Q1 2023, closing a stake of 65 shares — an estimated $3.15K sold.
Raleigh Capital Management first reported a position in STAA in Q3 2022 and held it in 2 quarters. The position peaked at $3.15K in Q4 2022. 251 funds tracked by Wall St. Rank hold STAA as of Q1 2023.
- Raleigh Capital Management reported no remaining STAAR Surgical position as of Q1 2023 after selling out during the quarter.
- Raleigh Capital Management sold 65 STAAR Surgical shares in Q1 2023, an estimated $3.15K.
- Raleigh Capital Management first reported a position in STAAR Surgical in Q3 2022 and held it in 2 quarters.
- Raleigh Capital Management's STAAR Surgical position peaked at $3.15K in Q4 2022.
- 251 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2023.
Based on Raleigh Capital Management's 13F filing for Q1 2023, filed 22 May 2023.